UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000038644
Receipt number R000042017
Scientific Title A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer.
Date of disclosure of the study information 2019/11/20
Last modified on 2022/01/06 10:12:12

No. Disposal Last modified on Item of update
1 Insert 2019/11/20 14:52:38
2 Update 2020/09/16 09:34:10 Recruitment status
Date of IRB
3 Update 2021/01/14 19:02:57 TEL
TEL
Tel1
4 Update 2021/01/14 19:03:40 Last follow-up date
5 Update 2022/01/06 10:12:12 Tel1
Email1